AcouSort Past Earnings Performance

Past criteria checks 0/6

AcouSort's earnings have been declining at an average annual rate of -17.2%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 18.4% per year.

Key information

-17.2%

Earnings growth rate

-10.0%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate18.4%
Return on equity-159.9%
Net Margin-234.2%
Next Earnings Update26 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How AcouSort makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:4SA Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 248-19260
30 Jun 248-19260
31 Mar 2410-18260
31 Dec 2311-17250
30 Sep 2312-13240
30 Jun 2311-13230
31 Mar 2310-14210
31 Dec 229-14200
30 Sep 227-15180
30 Jun 226-14170
31 Mar 226-13160
31 Dec 216-12150
30 Sep 216-12180
30 Jun 216-11140
31 Mar 217-9130
31 Dec 207-8130
30 Sep 206-8100
30 Jun 206-7120
31 Mar 204-9120
31 Dec 193-10120
30 Sep 193-9100
30 Jun 192-10100
31 Mar 193-8100
31 Dec 181-990
30 Sep 182-8100
30 Jun 182-790
31 Mar 182-710
31 Dec 172-680
30 Sep 173-550
30 Jun 173-330
31 Mar 173-250
31 Dec 163-100
30 Sep 162010
31 Dec 152000
31 Dec 142000
31 Dec 131000

Quality Earnings: 4SA is currently unprofitable.

Growing Profit Margin: 4SA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4SA is unprofitable, and losses have increased over the past 5 years at a rate of 17.2% per year.

Accelerating Growth: Unable to compare 4SA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4SA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: 4SA has a negative Return on Equity (-159.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AcouSort AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John WestborgRedeye